Interventional CT: 30 years' experience.
CT-guided procedures remain an important tool for diagnosis and tissue acquisition for primary diagnosis and molecular/tissue correlation. New imaging devices such as MDCT and PET/CT will improve diagnosis but percutaneous procedures will be needed to confirm and support new molecular and DNA treatments. Coagulopathic patients can be treated with LIBE a new method to prevent bleeding. Vasoactive drugs can be used to improve differentiation of malignant and benign diseases.
Department of Radiology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA. haaga@uhrad.com
John R
JR
Haaga
D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D001778:Blood Coagulation Disorders / Q000150:complications; D003287:Contrast Media; D004059:Diffusion of Innovation; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging*; D011835:Radiation Protection; D015641:Radiography, Interventional; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D003287:Contrast Media